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Abstract: Autophagy is an intracellular process that comprises degradation of damaged organelles,
protein aggregates and intracellular pathogens, having an important role in controlling the
fate of invading microorganisms. Intracellular pathogens are internalized by professional and
non-professional phagocytes, localizing in compartments called phagosomes. To degrade the
internalized microorganism, the microbial phagosome matures by fusion events with early and late
endosomal compartments and lysosomes, a process that is regulated by Rab GTPases. Interestingly,
in order to survive and replicate in the phagosome, some pathogens employ different strategies to
manipulate vesicular traffic, inhibiting phagolysosomal biogenesis (e.g., Staphylococcus aureus and
Mycobacterium tuberculosis) or surviving in acidic compartments and forming replicative vacuoles
(e.g., Coxiella burnetti and Legionella pneumophila). The bacteria described in this review often use
secretion systems to control the host’s response and thus disseminate. To date, eight types of secretion
systems (Type I to Type VIII) are known. Some of these systems are used by bacteria to translocate
pathogenic proteins into the host cell and regulate replicative vacuole formation, apoptosis, cytokine
responses, and autophagy. Herein, we have focused on how bacteria manipulate small Rab GTPases to
control many of these processes. The growing knowledge in this field may facilitate the development
of new treatments or contribute to the prevention of these types of bacterial infections.
Keywords: autophagy; Rab GTPases; bacterial pathogens; intracellular bacteria
1. Introduction
Interaction of Rabs, Autophagy and Intracellular Bacteria
Rab (Ras-related proteins in brain) GTPases are a family of proteins encoded by a group of at
least 60 genes. This must be considered as a minimum estimate, as a small part of the genome still
remains to be sequence [1]. Rab GTPases cycle between active and inactive states, GTP-bound or
GDP-bound forms, respectively. In the active conformation, Rabs interact with a high variety of
Rab-effector proteins to participate in membrane trafficking and intracellular signaling [2–4]. To date,
70 distinct Rab proteins have been identified, and each one is believed to be specifically associated
with a particular organelle or pathway. Rabs are present in all intracellular membrane compartments
(endoplasmic reticulum, Golgi, endosomes and lysosomes), at the plasma membrane, the nucleus [5]
and the mitochondria [6]. However, they are best known for their crucial roles in the endocytic and the
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exocytic pathways, in the regulated secretory paths where they control anterograde and retrograde
trafficking between compartments to manage cargo delivery and membrane recycling [6,7].
Autophagy is an intracellular process that involves degradation of damaged organelles, protein
aggregates and intracellular pathogens with a key role not only in maintaining cellular homeostasis
and guaranteeing adequate energy levels, but also as a defense mechanism against microorganisms, a
process specifically known as xenophagy [8,9].
Autophagy process involves the enclosure of cytoplasmic material by an isolation membrane,
called phagophore, which extends to form a double-membrane structure, the autophagosome that
finally fuses with lysosomes to degrade the trapped material [10–12]. Autophagosome formation is
regulated by at least 36 autophagy-related genes (Atg). The Atg1-UNC-51-like kinase (ULK) complex
triggers autophagy, then the PI3 (class III phosphatidylinositol 3) kinase complex produces PI3P
(essential component of autophagosome formation). Finally, the Atg12–Atg5–Atg16L1 ubiquitin-like
conjugation system, that mediates the elongation of the membrane and the conversion of LC3 I (the
mammalian orthologue of the yeast Atg8) to its phosphatidylethanolamine-conjugated LC3-II form,
participates in the closure of the phagophore to form the autophagosome [13].
Intracellular pathogens are internalized by professional phagocytes (macrophages, dendritic cells)
or non-professional phagocytes (epithelial cells) and localize into a vacuole, called phagosome. The
microbial phagosome matures by fusion events with early and late endosomal compartments and
lysosomes, which are controlled by Rab GTPases, to degrade the internalized microorganism [14–16].
Interestingly, in order to survive in the phagosome and replicate, pathogens employ a wide variety
of strategies to manipulate vesicular traffic, some can inhibit phagolysosomal biogenesis (e.g.,
Staphylococcus aureus or Mycobacterium tuberculosis) or survive in acidic compartments forming
replicative vacuoles (e.g., Coxiella burnetti or Legionella pneumophila) [17–20].
2. Intracellular Bacterial Pathogens: Interplay with Rabs and Autophagy
2.1. Mycobacterium Tuberculosis
Mycobacterium tuberculosis is the causative agent of tuberculosis (TB) in humans. This
microorganism employs a wide array of immune modulators to invade and proliferate in professional
phagocytic cells, such as macrophages, neutrophils, monocytes, and dendritic cells, inhibiting the
acidification of the phagosome and the recruitment of lysosomal enzymes [21,22]. Rab GTPases play
a key role in M. tuberculosis (Mtb) infection. Mtb modifies the recruitment of Rab proteins to the
phagosomal membrane, altering the signals necessary for proper maturation and late fusion with
lysosomes (Figure 1).
Once Mtb is phagocytosed, it resides in an early compartment characterized by the presence of
different Rab-GTPases, which transiently associate to the membrane to allow phagosomal maturation.
After 10 min of infection, Rab34 and Rab5 are recruited in high percentage (~85%) whereas Rab22
and Rab23 in low percentage (~30%). Rab22 and Rab23 are specific to early endosomes/phagosomes
and, after 1 h post-infection (p.i.), the recruitment to Mtb phagosomes decreases to 10%, indicating
maturation of the compartment [23]. Rab22a localizes to early endosomes, plasma membrane and
recycling pathways and, as mentioned above, it is recruited to Mtb phagosomal membrane at early
stages (i.e., 10 min p.i.) in a high proportion, and decreases to less than 10% after 60 min p.i. [4,23].
However, Rab22a has been recognized as a key Rab GTPase in Mtb phagosome maturation; its
role being evidenced by the conversion of mycobacterial phagosomes into a Rab7 positive vacuole
upon Rab22a knockdown. The latter phenomenon suggests that Rab22a confers signals to prevent the
acquisition of the late endosomal marker Rab7 and inhibits maturation into a late endosomal/lysosomal
compartment [24]. Hence, Mtb actively recruits and maintains Rab5 and Rab22a on its phagosome,
thus avoiding Rab7 acquisition and preventing phagolysosome biogenesis.
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Figure 1. Rab GTPases and vesicular trafficking modulation by Mycobacterium tuberculosis and 
Staphylococcus aureus. (A) M. tuberculosis initially resides in a phagosome characterized by the 
presence of Rab5, Rab10, Rab22b and Rab23 that matures to a late compartment. Approximately 1 h 
p.i. Mtb secretes ESAT-6, a pore forming toxin, and lyses the membrane promoting p62 and NDP52 
anchorage. Together, these proteins stimulate the autophagic pathway, and the damage phagosome 
is entrapped by an autophagosome. Rab5 remains in the phagosome, inhibiting the proper maturation 
of the compartment and as a consequence, it inhibits the lysosomal fusion. Finally, Mtb replicates 
inside the mycobacterial-containing phagosome (MCP). (B) S. aureus transits through an early 
phagosome with Rab5 and Rab22b that quickly maturates (15 min p.i.) to a late compartment marked 
by Rab7 and LAMP-1. Alpha hemolysin (Hla) is secreted by the bacteria and causes membrane 
damage. Autophagy is stimulated by the toxin and autophagosomes are recruited to the damage 
phagosome. Sa replicates inside the autophagosomes that does not mature to autophagolysosome due 
to the inhibition of lysosomal fusion. Then, phenol soluble modulin alpha (PMSα) mediates Sa escape 
to the cytoplasm, where bacteria continue replicating. 
Rab5 is associated with phagosomes immediately after phagocytosis and facilitates the 
recruitment of Rab5 effector proteins such as EEA1 (early endosomal autoantigen 1) and class III 
phosphatidylinositol-3-phosphate kinase (PI3K) [25]. In Mtb containing-phagosomes, Rab5 is 
recruited at early stages and its maintenance over time causes maturation disruption due to an 
inhibition of the Rab5–Rab7 switching. EEA1 is crucial for phagosomal maturation, and its 
recruitment to Mtb phagosomes is altered as a part of the mycobacterial phagosome maturation 
blockade. LAM, the heavily glycosylated mycobacterial phosphatidylinositol analogue, inhibits 
EEA1 recruitment to phagosomal membranes, which causes a disruption in the delivery of lysosomal 
hydrolases and Vo H+ ATPase from the Trans-Golgi network (TGN) to the phagosome [26,27]. 
Indeed, tuberculosis bacilli inhibits fusion of lysosomes with phagosomes through the selective 
exclusion of the GTPase Rab7 and lysosomal-associated membrane protein 1 (LAMP1) coupled with 
the retention of Rab5 on the phagosome [28]. Seto et al. have shown that Rab7 recruitment to Mtb 
phagosome decreases in a time-dependent manner, starting at 30 min p.i. at high levels (~80%) and 
decreasing after 180 min to approximately 30%. Cumulative data suggest that mycobacterial proteins 
and phagosomal membrane lipids may reduce Rab5-Rab7 conversion, specifically blocking the 
Figure 1. Rab GTPases and vesicular trafficking modulation by Mycobacterium tuberculosis and
Staphylococcus aureus. (A) M. tuberculosis initially resides in a phagosome characterized by the presence
of Rab5, Rab10, Rab22b and Rab23 that matures to a late compartment. Approximately 1 h p.i. Mtb
secretes ESAT-6, a pore forming toxin, and lyses the membrane promoting p62 and NDP52 anchorage.
Together, these proteins stimulate the autophagic pathway, and the damage phagosome is entrapped
by an autophagosome. Rab5 remains in the phagosome, inhibiting the proper maturation of the
compartment and as a consequence, it inhibits the lysosomal fusion. Finally, Mtb replicates inside the
mycobacterial-containing phagosome (MCP). (B) S. aureus transits through an early phagosome with
Rab5 and Rab22b that quickly maturates (15 min p.i.) to a late compartment marked by Rab7 and
LAMP-1. Alpha hemolysin (Hla) is secreted by the bacteria and causes membrane damage. Autophagy
is stimulated by the toxin and autophagosomes are recruited to the damage phagosome. Sa replicates
inside the autophagosomes that does not mature to autophagolysosome due to the inhibition of
lysosomal fusion. Then, phenol soluble modulin alpha (PMSα) mediates Sa escape to the cytoplasm,
where bacteria continue replicating.
Rab5 is associated with phagosomes immediately after phagocytosis and facilitates the
recruitment of Rab5 effector proteins such as EEA1 (early endosomal autoantigen 1) and class III
phosphatidylinositol-3-phosphate kinase (PI3K) [25]. In Mtb containing-phagosomes, Rab5 is recruited
at early stages and its maintenance over time causes maturation disruption due to an inhibition
of the Rab5–Rab7 switching. EEA1 is crucial for phagosomal maturation, and its recruitment to
Mtb phagosomes is altered as a part of the mycobacterial phagosome maturation blockade. LAM,
the heavily glycosylated mycobacterial phosphatidylinositol analogue, inhibits EEA1 recruitment to
phagosomal membranes, which causes a disruption in the delivery of lysosomal hydrolases and Vo H+
ATPase from the Trans-Golgi network (TGN) to the phagosome [26,27].
Indeed, tuberculosis bacilli inhibits fusion of lysosomes with phagosomes through the selective
exclusion of the GTPase Rab7 and lysoso al-associated e brane protein 1 (LA P1) coupled with
the retention of Rab5 on the phagoso e [28]. Seto et al. have shown that Rab7 recruit ent to tb
phagoso e decreases in a ti e-dependent manner, starting at 30 min p.i. at high levels (~80%)
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and decreasing after 180 min to approximately 30%. Cumulative data suggest that mycobacterial
proteins and phagosomal membrane lipids may reduce Rab5-Rab7 conversion, specifically blocking the
recruitment of RILP (Rab interacting lysosomal protein) to Rab7, or mycobacterial proteins may act as
Rab7-GAPs to inactivate Rab7 and inhibit interaction with RILP [29]. These alterations in phagosomal
maturation are key features to allow Mtb persistence and proliferation.
Recently, Cardoso et al. have demonstrated that Rab10, a Rab localized predominantly in
early endosomes and the Golgi, is also recruited to Mtb phagosomes and regulates the transition
of the nascent phagosome to an early phagosome. Hence, Rab10 is acquired even before
Rab5, acting upstream and modulating the maturation of Mycobacterium-containing phagosomes.
Indeed, the overexpression of the constitutively active mutant of Rab10 rescued the maturation of
live-Mycobacterium-containing phagosomes [30].
Mtb secretes multiple virulence factors via the general Sec and Tat pathways, and via specialized
ESX secretion systems, also called type VII secretion systems. The ESX-1 secretion system is an
important virulence factor which secretes the 6 kDa early secreted antigenic target (ESAT-6) and its
protein partner, the 10 kDa culture filtrate protein (CFP-10). Both ESAT-6 and CFP-10 are exported as a
heterodimer through the secretion system [31,32]. It has recently been shown that ESAT-6 inserts into
membranes and forms a membrane-spanning pore that damages the phagosomal membrane [33]. The
damage generated in the phagosomal membrane is a signal for autophagy induction. Adaptor proteins,
such as NDP52 and p62, recognize the damage and stimulate LC3 binding to phagosome membrane to
capture Mtb in an autophagosome [34]. Interestingly, Mtb can survive in the autophagosome due to its
ability to interrupt the autophagic flux, by avoiding Rab7 recruitment to form the amphisomes and,
as a consequence, interfering in autophagolysosome biogenesis [35]. Of note, nutritional starvation
has been demonstrated to promote the binding of LC3-II to the phagosomal membrane and the
maturation and acidification of Mycobacterium phagosomes by increasing the recruitment of late
endosomal/phagosomal markers (e.g., LAMP-1 and cathepsin D) directly affecting Mycobacterium
survival [36]. When autophagy is induced, it acts as a host’s defense mechanism against Mtb,
stimulating its lysosomal degradation. In contrast, when autophagy is not activated by starvation
or other stimuli, Mtb is capable of surviving inside autophagosomes by inhibiting lysosomal fusion
and, as a consequence, autophagolysosome biogenesis [34]. Moreover, Castillo et al. demonstrated
that the in vivo role of autophagy against tuberculosis is both antibacterial and anti-inflammatory.
Specifically, conditional gene-knockout mouse Atg5fl/fl LysM-Cre+ (Atg5 deletion on myeloid linage)
infected with Mtb showed increased infection and high pulmonary inflammation, characterized
by neutrophil infiltration and IL-17 response with augmented IL-1α levels. Thus, autophagy acts
in vivo suppressing bacilli growth and protecting against tissue necrosis and lung pathology [37].
Indeed, a recent work showed that Atg5 plays a unique role in protection against Mtb by preventing
polymorphonuclear-mediated immunopathology. Additionally, loss of Atg5 in polymorphonuclear
cells can sensitize mice to Mtb infection [38].
Rab8b has previously been shown to be recruited to Mtb phagosomes at late infection stages;
however, its role in Mtb infection was unknown [23]. Recently, Pilli et al. have shown that Rab8b is
involved in the autophagy clearance of Mtb var. bovis BCG. In addition, its downstream interacting
partner, the innate immunity regulator TBK-1, is necessary for the autophagic maturation. TBK-1
phosphorylates the autophagic adaptor p62 on Ser-403, a residue required for the autophagic function
of p62 [39,40].
Mycobacterial phagosome maturation is closely related to the autophagic pathway, but
Mtb-containing autophagosomes do not mature into autolysosomes. In conclusion, Mtb
takes advantage of Rab GTPases and of autophagy to establish a perfect replicative niche,
guaranteeing survival.
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2.2. Staphylococcus Aureus
Staphylococcus aureus causes a wide range of diseases in humans, from local infections
(e.g., dermatitis, folliculitis, and abscesses) to life-threatening systemic infections (e.g., endocarditis,
pneumonia, atherosclerosis, and septicemia). As a rule, S. aureus (Sa) has been considered an
extracellular pathogen, but increasing evidence indicates that this bacterium can invade cells and
replicate intracellularly, leading to staphylococcal persistence and chronic disease [41–44]. Sa initially
resides in a phagosome and replicates in this compartment by inhibiting lysosomal degradation, which
is accomplished by the secretion of toxins [45,46].
Rab GTPases are essential in Sa infection, participating in both phagosome formation and
maturation. At the early stage of infection (10 min approximately), the Sa-containing phagosome
acquires different markers, such as Rab5 and Rab22b at a percentage of 30% and 90% of the phagosomes,
respectively. Subsequently, these Rab GTPases decrease considerably and Rab8, Rab11, Rab20, Rab22a,
Rab32 and Rab38 are recruited transiently, peaking at 30 min and/or 1 h p.i. [23]. Even though the
specific role of Rab22b in Sa phagosome is not clear, it is well known that this molecule functions
in a vesicular transport route from the Trans-Golgi Network (TGN) to the early endosomes [47]. It
has recently been shown that Rab5 plays an important role in Sa infection, as demonstrated by the
reduced susceptibility to infection observed in cell knockdown for Rab5 [48], which likely affects
bacteria internalization.
The Rab6 GTPase plays important roles in the transit of proteins through the Golgi
complex, regulating the transport between Golgi, endoplasmic reticulum, plasma membrane and
endosomes [49–51]. A recent study has revealed that Rab6 is involved in the acidification of phagosomes
and that Rab6 mediates the phagocytosis of Sa affecting its proliferation, since silencing of Rab6
expression caused an important decrease in the clearance of live Sa by RAW 264.7 cells [52].
Rab7 is recruited to 40% of Sa-phagosomes at 10 min p.i. whereas at 30 min p.i., the proportion of
Rab7-positive phagosomes is higher than 80% and remains at this level until 6 h p.i. Localization of
Rab9, Rab34 and Rab39 has shown a similar kinetics pattern to Rab7 [23]. Remarkably, Sa-phagosomes
recruit Rab7 and LAMP-1, late compartment markers, but there is a blockade in the fusion with the
lysosomal degradative compartment evinced by the absence of acidic or degradative probes, such as
LysoTraker and DQ-BSA [53–55].
The Type VII secretion system, also termed Ess or ESX, is a key virulence determinant in Sa;
however, the exact function of any of the Ess substrate proteins remains to be elucidated [56]. The locus
on the Sa chromosome that controls the synthesis of a number of exoproteins has been vastly studied.
This locus, which has been named agr for “accessory gene regulator”, is a trans-activator of a series of
exoprotein genes. One important exoprotein that is controlled by the Sa agr system is the α-hemolysin
(α-toxin, Hla), which is a pore-forming toxin involved in membrane damage. Alpha hemolysin
is secreted as a 34 kDa soluble monomer that functions as a homo-heptameric pore-forming toxin.
Previous works carried out in our laboratory have demonstrated that the addition of the purified Hla
toxin to culture cells activates the autophagy pathway, evidenced by the accumulation of a large number
of vesicular structures decorated with the protein LC3 [55]. In addition, we have shown that wild type
Sa induces recruitment of LC3 to the phagosomal membrane, but the Hla-deficient strain (Sa 8325-4
Hla(-)) does not, indicating that the toxin secreted by the intracellular bacteria is also capable of
inducing autophagy [55].
Interestingly, Sa subverts autophagy and replicates inside the autophagosome to finally escape
to the cytoplasm, thus preventing lysosomal degradation [57]. Sa inhibits fusion of phagosomes
with lysosomes by a mechanism dependent on Staphylococcus-secreted toxins. The leaky phagosomes
undergo autophagy and Sa replicates within autophagosomes [57]. Eventually, Sa escapes to the host
cell cytoplasm by a process that is dependent on a phenol-soluble modulin (PSMα), a protein that has
cytolytic activity and belongs to the family of toxins that are soluble in phenols [58].
The regulation of the classical autophagy pathway involves a variety of proteins. One of
these proteins is the serine/threonine kinase mTOR (mammalian target of rapamycin), which
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inhibits autophagy [59,60]. On the other hand, autophagy is regulated by the Class III
phosphatidylinositol-3-kinase (PI3K), which activates the autophagic pathway. Class III PI3K, and
its human orthologue hVps34, interact with Beclin-1 and p150 myristoylated kinase, activating some
of the Atg proteins involved in the autophagic pathway [61]. Of note, the Sa-activated autophagy
occurs through a PI3K/Beclin-1 independent pathway, indicating that the activation is through a
non-canonical mechanism. Indeed, we have shown that cAMP is able to inhibit Hla-induced autophagy
and that PKA, the classical cAMP effector, does not participate in this regulation. Furthermore, we have
shown that EPAC and its effector Rap2b are involved in the regulation of Hla-induced autophagy [62].
Sa takes advantage of intracellular trafficking, modulating Rab GTPases recruitment to the
phagosome and activating autophagy. These processes are accomplished, at least in part, through
membrane damage, creating a replicative niche and avoiding degradation.
2.3. Coxiella Burnetii
As mentioned above, the autophagic pathway has been revealed as a component of the innate
immune response against intracellular microorganisms. Nevertheless, pathogens like Coxiella burnetii
(hereafter Coxiella) benefit from this cellular response and subvert the autophagy process resulting in a
more efficient replication [63].
Coxiella is an obligate intracellular bacterium which is the causative agent of Q fever in humans
and of coxiellosis in animals. This microorganism has developed strategies to survive in the harshest
of the intracellular compartments: the phagolysosome. After internalization, the budding Coxiella
phagosome eventually develops into a great and spacious parasitophorous vacuole (PV) that acquires
lysosomal features such as acidic pH, acid hydrolases and cationic peptides, which are defense barriers
aimed at clearing infectious agents from the host [64].
Coxiella actively contributes to the biogenesis of its PV by producing proteins that mediate
phagosome stalling, autophagic interactions, and expansion and maintenance of the mature vacuole.
Among the potential mechanisms facilitating these processes, Coxiella has the Dot/Icm type IV secretion
system (T4SS). This system delivers bacterial effector proteins to the host cytosol, where they alter
cellular processes to benefit the pathogen [64–68]. Specifically, the Coxiella T4SS translocates effectors
when the pathogen becomes metabolically active in an acidified vacuole. The function of the T4SS
is essential for intracellular replication of Coxiella, since mutants defective in this virulence factor are
incapable of growing efficiently in the intracellular environment [69,70].
During infection, Coxiella is able to regulate host trafficking pathways by the selective retention of
Rabs on membranes of the PV [71] (Figure 2). The small Rab GTPases regulate vesicular trafficking
and autophagy [72]. In eukaryotic cells, organelle identity is determined, in part, by the presence of
active Rabs on the membranes of each organelle. Some protein effectors ejected by Coxiella may work
as specific receptors for Rabs GTPases or as enzymes that post-translationally modify Rab proteins or
endosomal membrane lipids essential for Rab functions [29].
Several works have described the role and distribution of Rab GTPases during Coxiella infection
and its relationship with autophagy. This bacterium transits through the normal endo/phagocytic
pathway actively interacting with autophagosomes at early stages p.i.. Coxiella phagosomes acquire
Rab5 and Rab7 proteins sequentially during infection, and colocalize with the marker of acidic
compartments LysoTracker and the autophagy markers monodansylcadaverine (MDC) and LC3.
The LC3 acquisition appeared to be a bacterially-driven process, because it is inhibited by the
bacteriostatic antibiotic chloramphenicol [73]. Furthermore, the inhibition of the autophagic process
with 3-methyladenine or wortmannin blocked Coxiella vacuole formation in HeLa cells [74]. Moreover,
the overexpression of LC3 or the GTPase Rab24 in CHO cells accelerates the development of Coxiella
vacuoles. In contrast, overexpression of mutants of those proteins that cannot be targeted to
autophagosomes dramatically decrease the number and size of the vacuoles in the first hours of
infection [75].
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Figure 2. Intracellular trafficking route of Coxiella and Legionella. (A) Coxiella initially resides in a 
parasitophorous vacuole (PV) that takes hours to days to mature into a compartment resembling a 
lysosome. Rab5 and Rab7 have been shown to be sequentially present on the PV, with Rab5 showing 
maximal recruitment approximately 20 min p.i. before being replaced by Rab7 which remains on the 
PV throughout the infection. Between 6 and 12 h post- infection, the PV acquires autophagy markers 
including LC3 and Rab24. Then, p62 colocalizes with LC3 on PV membranes containing ubiquitinated 
proteins without affecting the bacterial replication. In addition, Rab1b labels the PV membrane at later 
p.i. times (6 h). (B) Legionella actively evades endocytic trafficking and creates an ER-derived niche. 
Effector proteins such as DrrA/SidM, LidA, and RalF, secreted by the T4SS, prolong the association 
with the ER and inhibit the immediate delivery to lysosomes. Likewise, RavZ cleaves the membrane-
conjugated LC3 from pre-autophagosomal structures to persist in immature autophagosomal 
vacuoles for a period of time that is suitable to differentiate into an acid-resistant replicative form. 
Then, the subsequent secretion of the effector LepB releases the block to autophagosome maturation, 
and the adapted progeny continues to replicate within autophagolysosomes. 
In addition to the interaction of Coxiella phagosomes with both the endocytic and the autophagic 
pathways, our laboratory has reported that the Coxiella PV also intercepts the secretory pathway. 
Rab1b is a small GTPase responsible for the anterograde transport between the endoplasmic 
reticulum and the Golgi apparatus. It has been demonstrated that Rab1b is recruited to the PV at later 
infection stages (6 h p.i.) and, interestingly, the knockdown of Rab1b altered the vacuole growth, 
indicating that this protein is required for a suitable biogenesis of the Coxiella PV. In addition, 
disruption of the secretory pathway by chemical inhibitors or by overexpression of mutant proteins, 
affected the typical size of the PV [78]. 
Due to an extended growth cycle, Coxiella continuously manipulates cellular processes to 
generate the PV and to increase host cell viability. Thus, Coxiella is able to modulate several host 
signaling pathways to ensure survival and intracellular replication [79]. In addition to the influence 
Figure 2. Intracellular trafficking route of Coxiella and Legionella. (A) Coxiella initially resides in a
parasitophorous vacuole (PV) that takes hours to days to mature into a compartment resembling
a lysosome. Rab5 and Rab7 have been shown to be sequentially present on the PV, with Rab5
showing maximal recruitment approximately 20 min p.i. before being replaced by Rab7 which
remains on the PV throughout the infection. Between 6 and 12 h post- infection, the PV acquires
autophagy markers including LC3 and Rab24. Then, p62 colocalizes with LC3 on PV membranes
containing ubiquitinated proteins without affecting the bacterial replication. In addition, Rab1b
labels the PV membrane at later p.i. times (6 h). (B) Legionella actively evades endocytic trafficking
and creates an ER-derived niche. Effector proteins such as DrrA/SidM, LidA, and RalF, secreted
by the T4SS, prolong the association with the ER and inhibit the immediate delivery to lysosomes.
Likewise, RavZ cleaves the membrane-conjugated LC3 from pre-autophagosomal structures to
persist in immature autophagosomal vacuoles for a period of time that is suitable to differentiate
into an acid-resistant replicative form. Then, the subsequent secretion of the effector LepB
releases the block to autophagosome maturation, and the adapted progeny continues to replicate
within autophagolysosomes.
Autophagy is an essential process modulated by the T4SS during Coxiella infection. Via this system,
the pathogen actively recruits autophagosomes to the PV to deliver nutrients and provide membrane
for the expanding vacuole. Accordingly, interactions with autophagosomes are necessary for the PV
maturation to a phagolysosome-like compartment. Coxiella effector proteins control interactions with
autophagosomes in macrophages at early stages of infection; and this progression is necessary for
PV fusion with lysosomes. Winchell et al. have demonstrated the localization of LC3 and p62 in the
wild type Coxiella PV but their absence in T4SS mutant organism-containing phagosomes in human
macrophage-like cells, primary human alveolar macrophages and CHO cells [76]. However, while
the lipidated LC3 levels were elevated regardless of the T4SS activity, p62 levels remained constant
during Coxiella growth, suggesting that the pathogen does not promote the turnover of the autophagic
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p62 [77]. Altogether, these evidences suggest that the transit through the autophagic pathway increases
the bacterial load by providing a favorable niche for the intracellular differentiation and survival.
In addition to the interaction of Coxiella phagosomes with both the endocytic and the autophagic
pathways, our laboratory has reported that the Coxiella PV also intercepts the secretory pathway. Rab1b
is a small GTPase responsible for the anterograde transport between the endoplasmic reticulum and
the Golgi apparatus. It has been demonstrated that Rab1b is recruited to the PV at later infection stages
(6 h p.i.) and, interestingly, the knockdown of Rab1b altered the vacuole growth, indicating that this
protein is required for a suitable biogenesis of the Coxiella PV. In addition, disruption of the secretory
pathway by chemical inhibitors or by overexpression of mutant proteins, affected the typical size of
the PV [78].
Due to an extended growth cycle, Coxiella continuously manipulates cellular processes to generate
the PV and to increase host cell viability. Thus, Coxiella is able to modulate several host signaling
pathways to ensure survival and intracellular replication [79]. In addition to the influence in autophagy,
Coxiella also regulates apoptosis to its own benefit. These effects are achieved through the Beclin 1/Bcl-2
interplay. We have demonstrated that Beclin 1 is recruited to the Coxiella-membrane vacuole, favoring
development and bacterial replication. In contrast, the anti-apoptotic protein Bcl-2 alters the normal
development of the Coxiella replicative compartment, even though it is also recruited to the vacuole
membrane [80]. Regarding apoptosis regulation, this pathogen is also capable of activating the
pro-survival kinases Akt and Erk1/2 to increase host viability [79].
Although Rab GTPases and pathways such as autophagy and apoptosis are important targets of
Coxiella infection, there are yet underexplored functions of bacterial effectors involved in the generation
of the replicative PV.
2.4. Legionella Pneumophila
The severe pneumonia known as Legionnaires' disease follows the infection of the gram-negative
bacterium Legionella pneumophila (hereafter Legionella). This pathogen can be engulfed by eukaryotic
phagocytes. As an escape mechanism, Legionella has developed a complex system of effector proteins
which allow the bacterium to survive within the phagocytic vacuole, thus escaping from the host’s
defense mechanisms and replicating within a self-tailored compartment. The course of infection can be
divided into five main phases: 1- pathogen uptake, 2- formation of the replication-permissive vacuole,
3- intracellular replication, 4- host cell response, and 5- bacterial exit. Legionella effector proteins
target every stage of this process, interacting with the secretory, endosomal, lysosomal and autophagy
pathways, as well as with mitochondria [81].
Similarly to Coxiella, one virulence strategy used by Legionella is to manipulate host cellular
processes using bacterial proteins that are delivered into the cytosolic compartment of the host cell by
the specialized T4SS [82]. The pathogen translocates more than 300 bacterial proteins, whose functions
are mostly still unknown. Nevertheless, several investigations suggest their roles in the modulation of
diverse host processes such as vesicle trafficking, autophagy, ubiquitination, and apoptosis [83,84]. In
the next paragraphs, the Legionella effectors mediating functions in vesicle trafficking and autophagy
are discussed.
After phagocytosis, Legionella actively evades endocytic trafficking and creates an ER derived
niche. The biogenesis of Legionella-containing vacuoles and autophagosomes share several features,
including the presence of ER-derived membranes [85–87]. However, Legionella has also acquired
mechanisms to initially evade the autophagic pathway [88]. Within the first hours of infection,
it has been demonstrated that effector proteins such as DrrA/SidM, LidA, and RalF, secreted
by the T4SS, prolong the association time of the vacuole with the ER and inhibit the immediate
delivery to lysosomes [85]. Moreover, it has recently been described that the effector RavZ cleaves
the membrane-conjugated LC3 from autophagosomal structures [89]. Thus, bacteria persist in
immature autophagosomal vacuoles for a period that is suitable for them to differentiate into an
acid-resistant replicative form [90]. Then, the subsequent secretion of the effector LepB releases
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the block to autophagosome maturation, and the adapted progeny continues to replicate within
autophagolysosomes [85]. By 18 h p.i., a significant proportion of vacuoles contain LAMP-1, cathepsin
D, and acidic pH [90], and are labeled by autophagic proteins [86].
Among the diverse set of regulatory molecules affected by the T4SS effectors, small host GTPases
seem to be prominent and significant targets. The master regulators of vesicular trafficking, Rab
proteins, are mainly targeted by Legionella proteins, and among these, Rab1 undergoes the most diverse
modifications [91]. Legionella affects the intracellular vesicular trafficking of infected eukaryotic cells
by recruiting the small GTPase Rab1 to the cytosolic side of the pathogen-containing vacuole. In order
to achieve this process, the Legionella effector DrrA contains a specific guanine nucleotide exchange
activity for Rab1 activation that exchanges guanosine triphosphate (GTP) for guanosine diphosphate
(GDP) on Rab1. Thus, DrrA restricts the access of GTPase activating proteins, thereby maintaining Rab1
constitutively active [92]. On the other hand, by crystal structure studies and biochemical analyses, it
has been demonstrated that LepB can inactivate Rab1 by acting as a GTPase-activating protein (GAP).
Surprisingly, LepB can additionally operate as a GAP for Rab3, Rab8, Rab13 and Rab35, suggesting
that it has a broader cellular role than it was previously thought [93].
Additionally to the non-covalent modifications that modify the nucleotide binding state of Rab1,
the bacterium also uses covalent modifications such as adenylation (AMPylation) to manipulate the
dynamics of Rab1 on the Legionella-containing vacuole [94]. It has been described that the AMPylation
of Rab1 by SidM can be reversed by the Legionella effector SidD [94,95], indicating that Legionella may
also use covalent modifications in order to alter the activity of Rab proteins.
Another Legionella effector protein, the Lpg0393, which interacts with Rabs from the endocytic
pathway, has recently been identified. Due to its similar structure to the catalytic core of Rabex-5 which
activates Rab5, Rab21 and Rab22, Lpg0393 exhibits a guanine-nucleotide exchange factor activity
toward endosomal Rabs [96]. Since the Rab5 sub-cluster members mediate endocytosis and endosomal
maturation, and the Legionella vacuole gathers membrane materials from endoplasmic reticulum,
the activity of these Rabs may increase vesicle traffic from endosomes to trans Golgi network and
eventually to the PV.
In addition, mass spectrometry studies have evidenced the interactions of the effector PieE with
multiple Rab GTPases, including Rab1a, Rab1b, Rab2a, Rab5c, Rab6a, Rab7, and Rab10. The binding
of the Rab GTPases with PieE was validated by yeast two-hybrid binding assays [83]. Nevertheless,
the specific role of PieE remains to be elucidated.
LidA is another effector protein ejected by the Legionella T4SS that interacts with several host
GTPases of the Rab family, including Rab6a, a regulator of retrograde vesicle trafficking within
eukaryotic cells. LidA preferentially binds Rab6a in the active GTP-bound conformation by efficiently
blocking the hydrolysis of GTP, even in the presence of cellular GTPase-activating proteins [97]. The
role of Rab6a for Legionella growth within host cells is still unclear but evidence suggests that its
function must be important for efficient intracellular bacteria replication.
The small GTPase Ran has been proved to play a role in a variety of cellular processes,
such as nuclear pore translocation, mitotic spindle assembly and post-mitotic nuclear envelope
formation. Furthermore, Ran plays an important role in cytoplasmic events involving non-centrosomal
microtubules, such as endocytic receptor trafficking and the specific retrograde signaling along
microtubules in nerve axons [98]. Lately, it has been found that Ran decorates the Legionella-containing
vacuole. In macrophages infected by Legionella, Ran is activated by the T4SS substrate LegG1, leading
to microtubule stabilization and promoting intracellular pathogen vacuole motility and bacterial
growth, as well as chemotaxis and migration of Legionella-infected cells [99].
Legionella-infected cells also exhibit resistance to apoptotic stimuli due to the presence of bacterial
effector proteins. SidF is a Legionella effector that prevents infected cells from undergoing apoptosis and
thus allows maximal bacterial multiplication. SidF contributes to apoptosis resistance by specifically
interacting with and neutralizing the effects of BNIP3 and Bcl-rambo, two pro-apoptotic members
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of the Bcl2 protein family [84]. Therefore, the inhibition of host pro-death proteins by translocated
effectors constitutes a mechanism to protect host cells from apoptosis.
Legionella uses hundreds of effectors in order to direct cellular processes such as membrane
trafficking and innate immune responses. The rigorous spatiotemporal regulation of their functions
is likely to be needed for the modulation of distinct host cell events at different phases of
infection as bacterial replication and the exit from the vacuole following replication. Further
work is necessary to elucidate the functional role of Legionella effectors to provide new concepts
in host–pathogen interactions.
3. Conclusion
Intracellular bacterial pathogens produce a variety of human diseases and cause significant
morbidity and mortality in humans. Pathogens must manipulate the host cell to obtain the nutrients
required for proliferation and subsequent pathogenesis. The bacteria described in this work often
employ secretion systems to manipulate host processes for replication and dissemination. Through
eight types of secretion systems (Type I to Type VIII), bacteria translocate pathogenic effector proteins
into the host cytosol. Translocated effectors control several infection events, including the replicative
vacuole formation, apoptosis, cytokine responses, and autophagy.
Autophagy is a degradation process where cellular cargos are delivered to the lysosomes. Initially
considered as a response activated under stress conditions, mainly nutrient deficit, autophagy is now
known to impact diverse pathophysiological conditions like aging, neurodegeneration, inflammation
and infection. Not surprisingly, many intracellular pathogens including Listeria, Shigella, Salmonella,
Mycobacterium and Staphylococcus are known to evade autophagy. However, others such as Helicobacter
pylori, Coxiella and Legionella have developed sophisticated strategies to survive and replicate inside
the hostile environment of a lysosome-derived organelle.
We have learned that these pathogens are able to handle a wide variety of host cell processes but
further studies are needed to elucidate the role of bacterial effectors in manipulating host autophagy
to clarify the pathogenesis of intracellular bacterial infections.
In summary, the study of the coordinated actions of bacterial effector proteins controlling Rab
functions to promote bacterial survival, and the different strategies aimed at establishing the replicative
vacuoles, is a fascinating area of research. Future work in this field must continue to expand our
knowledge about the molecular mechanisms driving autophagy to target bacteria and the specific host
factors necessary to eliminate invading pathogens. We believe that this knowledge may facilitate the
development of treatments or the prevention of infections caused by these types of pathogens through
the promotion of the use of autophagy modulators as antimicrobial agents.
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